Status:
COMPLETED
Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Collaborating Sponsors:
University of Hull
Conditions:
Femoropopliteal Disease
Intermittent Claudication
Eligibility:
All Genders
Phase:
NA
Brief Summary
Intermittent Claudication (IC)is a common condition characterised by pain in the muscles of the legs on exertion caused by "hardening of the arteries" and a reduced blood supply. The investigators kno...
Detailed Description
Intermittent claudication (IC) is a common problem in the UK's elderly population with a prevalence of 5 -10%. Intermittent claudication infers significant quality of life limitations, however, it is ...
Eligibility Criteria
Inclusion
- Symptomatic unilateral Intermittent Claudication Femoro-popliteal lesion Angioplastiable lesion on duplex \> 3 months on BMT
Exclusion
- Critical ischaemia Incapacitating systemic disease Inability to tolerate treadmill testing Ischaemic changes on ECG during treadmill testing Ipsilateral surgery / PTA in previous 6 months
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00798850
Start Date
August 1 2002
End Date
November 1 2010
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Vascular Surgery Unit, Vascular Laboratory, Alderson House, Hull Royal Infirmary
Hull, East Riding Of Yorkshire, United Kingdom, HU3 2JZ